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Summary
Autosomal dominant nocturnal frontal-lobe epilepsy
(ADNFLE) is a recently identified partial epilepsy in
which two different mutations have been described in
the a4 subunit of the neuronal nicotinic acetylcholine
receptor (CHRNA4). An additional seven families are
presented in which ADNFLE is unlinked to the
CHRNA4 region on chromosome 20q13.2. Seven ad-
ditional sporadic cases showed no evidence of defective
CHRNA4. One of the families showed evidence of link-
age to 15q24, close to the CHRNA3/CHRNA5/
CHRNB4 cluster (maximum LOD score of 3.01 with
D15S152). Recombination between ADNFLE and
CHRNA4, linkage to 15q24 in one family, and exclusion
from 15q24 and 20q13.2 in others demonstrate genetic
heterogeneity with at least three different genes for
ADNFLE. The CHRNA4 gene and the two known
CHRNA4 mutations are responsible for only a minority
of ADNFLE. Although the ADNFLE phenotype is clin-
ically homogeneous, there appear to be a variety of mo-
lecular defects responsible for this disorder, which will
provide a challenge to the understanding of the basic
mechanism of epileptogenesis.
Introduction
Autosomal dominant nocturnal frontal-lobe epilepsy
(ADNFLE; MIM 600513) is a recently identified idio-
pathic partial epilepsy (Scheffer et al. 1994, 1995). This
epilepsy syndrome is characterized by clusters of frontal-
lobe motor seizures occurring during sleep. Onset is usu-
ally in childhood, and inheritance is autosomal domi-
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nant, with 75% penetrance. The condition is clinically
distinctive and relatively homogeneous, although seizure
severity and specific frontal-lobe seizure manifestations
vary within families (Scheffer et al. 1995; Hayman et al.
1997). Misdiagnosis as nightmares, night terrors, other
parasomnias, or even psychiatric disorders is common
if clinicians are unaware of ADNFLE.
The gene for ADNFLE in one large Australian family
was mapped to 20q13.2 (Phillips et al. 1995). In this
family the molecular defect was found to be a CrT
transition that replaces serine by phenylalanine at codon
248 in the a4 subunit of the neuronal nicotinic acetyl-
choline receptor (CHRNA4) (Steinlein et al. 1995). The
molecular defect of the same gene in a second ADNFLE
family, of Norwegian origin, has been characterized as
an insertion of a GCT triplet between codons 259 and
260 (Steinlein et al. 1997). Thus far, these are the only
two mutations detected for ADNFLE, and both have
been shown to have major effects on receptor function
in vitro (Weiland et al.1996; Kuryatov et al. 1997; Stein-
lein et al. 1997).
Several genes for other idiopathic epilepsies have been
mapped. These include benign familial neonatal con-
vulsions (20q13.2 and 8q) (Leppert et al. 1989; Lewis
et al. 1993), partial epilepsy with auditory symptoms
(10q22-q24) (Ottman et al. 1995), familial febrile sei-
zures (8q13-q21 and 19p13.3) (Wallace et al. 1996;
Johnson et al. 1998), and benign familial infantile con-
vulsions (19q and 16) (Guipponi et al. 1997; Szepe-
towski et al. 1997). Thus, at least three of these mono-
genic epilepsies demonstrate locus heterogeneity. For
benign neonatal familial convulsions, the only idiopathic
epilepsy (apart from ADNFLE) in which genetic defects
have been identified, the two genes code for homologous
potassium channels (Biervert et al. 1998; Charlier et al.
1998; Singh et al. 1998).
Our preliminary studies of additional families with
ADNFLE suggest that they do not show linkage to the
CHRNA4 locus at 20q13.2 (Berkovic et al. 1995). There
are several neuronal nicotinic acetylcholine–receptor
subunits (a2–a9 and b2–b4), and each functional re-
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ceptor is composed of five subunits; the most common
functional receptor in brain is thought to be composed
of two a4 subunits and three b2 subunits (Schoepfer et
al. 1988; Whiting et al. 1991; Sargent 1993). Given the
involvement of CHRNA4 in ADNFLE, the other neu-
ronal nicotinic acetylcholine–receptor subunits have
emerged as candidates for ADNFLE and, possibly, other
idiopathic epilepsies (Elmslie et al. 1997) in families
which do not map to CHRNA4. Known locations of
other subunits expressed in brain are 1p21 (b2), 8p11.2
(b3), 8p21 (a2), 15q13 (a7), and 15q24 (a3, a5, and
b4).
We now show that the two reported CHRNA4 mu-
tations are uncommon among patients with familial or
sporadic nocturnal frontal-lobe epilepsy. We also show
that seven ADNFLE families are not linked to the
CHRNA4 locus, and, in one of these families, we find
linkage to markers on chromosome 15, near the
CHRNA3/CHRNA5/CHRNB4 cluster.
Subjects and Methods
Subjects
A. Familial cases.—Multigenerational families in
which DNA was available from at least four individuals
affected with ADNFLE were selected for study (fig. 1).
The probands had idiopathic nocturnal frontal-lobe ep-
ilepsy with the characteristics defined elsewhere (Scheffer
et al. 1995), and affected relatives had similar clinical
patterns with variable severity. Families C, D, G, and O
have not been reported elsewhere and are of Italian,
Scottish, French Canadian, and Swedish origin, respec-
tively. Families S (Australian) and M (English) were re-
ported, in part, as pedigrees B and C, respectively, in
Scheffer et al. (1995). These two pedigrees have been
considerably extended, with new affected individuals
having been identified. Family Q is of French Canadian
origin and has been reported elsewhere (Lopes-Cendes
et al. 1995; Scheffer et al. 1995).
B. Sporadic Cases.—Subjects with idiopathic noctur-
nal frontal-lobe epilepsy and a negative family history
of seizures, despite careful inquiry, were studied. Inclu-
sion criteria were onset of seizures at age !25 years,
partial seizures with frontal-lobe semiology, x90% of
seizures occurring during sleep, normal intellect, normal
neurological examination, and normal magnetic-reso-
nance imaging. Magnetic-resonance scans were carefully
scrutinized, to exclude subtle dysplastic abnormalities.
There were seven Australian subjects (four females) with
seizure onset at age 2–21 years (mean 8 years).
Mutation analysis
All families and sporadic cases were tested for the two
known mutations in CHRNA4 (Steinlein et al. 1995,
1997), by single-strand conformation analysis (SSCA)
and direct DNA sequencing using primers 8 and 11 (ta-
ble 1). They were screened for novel mutations by SSCA
within exons 2 and 4–6 and by sequencing across the
transmembrane domains I–III. Exon 3 was too small (55
bp), and exon 1 was too GC rich, for easy analysis, and,
since exons 5 and 6 contain the main coding region,
which includes the four conserved transmembrane do-
mains and the sites of the two known mutations, exons
1 and 3 were not examined. Primers used for SSCA and
sequencing of CHRNA4 are shown in table 1. These
were designed directly from the cDNA sequence
(GenBank accession number U62433), by means of the
chicken CHRNA4 genomic organization (GenBank ac-
cession numbers X07348–X07352 and X07399), to in-
fer likely locations of intron-exon boundaries. Exons 5
and 6 of CHRN subunits b2, b4, a3, and a5 were an-
alyzed by SSCA (primers are available from the corre-
sponding author, on request). All SSCA variants were
sequenced to determine the molecular basis of the
variation.
PCR reactions for SSCA were performed on 100 ng
of genomic DNA in a total volume of 10 ml containing
1.5 mMMgCl2, 2 mCi of [
32P]-dCTP, and 150 ng of each
primer. Cycling was at 94C for 1 min, 60C for 1.5
min, and 72C for 1.5 min (10 cycles) and at 94C for
1 min, 55C for 1.5 min, and 72C for 1.5 min (25
cycles), followed by 10 min at 72C, in a Perkin-Elmer
thermocycler. PCR products were run on 6% and 10%
nondenaturing polyacrylamide gels containing 5% glyc-
erol and on MDE gels (FMC BioProducts), according to
the manufacturer’s instructions. DNA sequencing was
performed by means of a Perkin-Elmer Ready Reaction
Dye Terminator Kit, in a Perkin-Elmer thermocycler,
with 25 ng of primer and ∼70 ng of double-stranded
PCR product as template.
Linkage Analysis
Observations of recombination between ADNFLE
and intragenic CHRNA4 markers were used to exclude
linkage of ADNFLE to CHRNA4 in the seven families.
The intragenic CHRNA4 polymorphisms described else-
where consist of three CfoI polymorphisms, at positions
594 (Steinlein 1995), 1545 (Phillips and Mulley 1997),
and 1575 (Phillips and Mulley 1997) and an AC di-
nucleotide-repeat polymorphism in intron 1 (Weiland
and Steinlein 1996). A family-specific intragenic
CHRNA4 variant detected by SSCA and sequencing (see
Results) was used to exclude linkage to CHRNA4 in
family S.
LOD scores, between ADNFLE and chromosome 15
markers from the Ge´ne´thon linkage map (Dib et al.
1996), were calculated by MLINK (Lathrop and Lalouel
1984). Only affected family members were used to ex-
Figure 1 Families studied. Markers within CHRNA4 used to show recombination with ADNFLE are the AC dinucleotide repeat in intron
1 (Weiland and Steinlein 1996) for families C, D, G, M and O, the CfoI polymorphism at 594 (Steinlein 1995) for family Q and the private
variant described in the text for family S.
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Table 1
Primer Pairs Used in SSCA and Sequencing of CHRNA4
A. Exons and Primer Pairs Used
Exon(s) Primer Pair(s)
2 1-2
4 3-4
5 5-7, 5-9, 5-10; 6-9, 6-10a; 8-10, 8-11a; 12-14;
13-14, 13-17; 15-17, 15-20a; 16-20; 18-20
5 and 6 19-22
6 21-22a
B. Primer Sequences
Primer Sequence
1 ACGCCGAGGAGCGGCT
2 CACGTCAATGAGCTGAG
3 GAGTGGCACGACTACAAGCT
4 TTGTTGTAGAGGACGATGTCCGGC
5 CGGCCATTTACAAGAGCTCC
6 GGCGAGTGGGTCATCGTGG
7 TAGGTGATGTCCGGGTAGAT
8 TCACCTATGCCTTCGTCATC
9 GGTGAGCGACAGCAGCAC
10 ATGACCAGTGAGGTGGACG
11 TGGCACGATGTCCAGGAAGA
12 TCTTCCTGGACATCGTGCCA
13 TTCCTGCAAGTCACCCT
14 GGGAACACAGTACTGGAT
15 ATCCAGTACTGTGTTCCC
16 AAGGAGCCCTCTTCGGTGTC
17 TTTGGTGCTGCGGGTCTTGA
18 TCAAGACCCGCAGCACCAAA
19 GTCCAGTACATTGCAGACCA
20 CGAGAAGTCTGTGTCTTC
21 GTGAAGGAGGACTGGAAGTA
22 TCCCTTCCTAGATCATGCCA
a Primer pair also was used for sequencing of both DNA strands
of PCR product.
clude linkage, by recombination, and to demonstrate
linkage, by LOD-score analysis, since penetrance may
vary, depending on the gene or mutation involved. The
locations of CHRNA3, CHRNA5, and CHRNB4 were
determined in relation to Ge´ne´thon markers on chro-
mosome 15, by means of the Stanford G3 radiation-
hybrid panel (Stewart et al. 1997).
Results
CHRNA4
None of the seven families or any of the sporadic cases
had either of the two known mutations, nor did they
have any other mutation detectable by SSCA, in the parts
of the gene analyzed. Sequencing of those parts of the
gene containing transmembrane domains confirmed this
result. Mutation analysis did, however, reveal a number
of benign polymorphisms, as described above (Subjects
and Methods), and a rare variant, in exon 5, peculiar
to family S (not seen in 129 unrelated individuals) when
primer pair 8-11 was used (table 1). This is a noncon-
servative TrG transition, which effects an isoleucine-to-
serine change in the conserved transmembrane I domain,
at codon 229, according to the sequence nomenclature
of Steinlein et al. (1996), or codon 257, according to
the sequence given by GenBank. This variant shows
Mendelian inheritance but does not show 1:1 segrega-
tion with the ADNFLE in family S (fig. 1).
Linkage analysis using intragenic polymorphisms de-
scribed above (Subjects and Methods) and an intragenic
marker detected, in this study, in family S showed that
ADNFLE in these families is not due to mutation of
CHRNA4 (fig. 1). In family C, neither III-1 nor III-2
received a copy of CHRNA4 from the affected grand-
father (I-2). In family D, affected individuals IV-2 and
IV-4 received different copies of CHRNA4. In family G,
affected individuals III-1 and III-2 inherited different
CHRNA4 alleles from their affected mother (II-1). In
family M, affected individual IV-2 did not inherit a copy
of CHRNA4 from her carrier grandmother (II-2). In
family O, affected individual III-1 did not receive a copy
of the gene from his grandfather (I-1). In family Q, af-
fected individual IV-5 did not inherit a copy ofCHRNA4
from her nonpenetrant grandfather (II-5). In family S,
the affected individual IV-3 did not inherit a copy of
CHRNA4 from her obligate-carrier grandmother (II-3),
as determined by the segregation of the rare variant spe-
cific to this family. Thus, recombination between ADN-
FLE and CHRNA4 in affected members in all of these
families excludes linkage to CHRNA4 and, hence, dem-
onstrates genetic heterogeneity for ADNFLE.
CHRNB2
SSCA analysis of transmembrane-domain regions of
exons 5 and 6, in all families and sporadic cases, failed
to detect any band shift. Linkage analysis using intra-
genic CHRNB2markers was not possible, since no poly-
morphisms were observed by SSCA.
CHRNA3, CHRNA5, and CHRNB4
Ge´ne´thon markers from the chromosome 15 region
containing CHRNA3, CHRNA5, and CHRNB4 were
used to look for linkage in the seven ADNFLE families.
The largest family (family M) showed linkage to chro-
mosome 15 (table 2). The maximum LOD score was
3.01 at recombination fraction of 0, with the fully in-
formative marker D15S152. The haplotype of markers
in family M that is consistent with linkage of ADNFLE
to the long arm of chromosome 15 is given in figure 2.
The regional localization as determined from data for
family M is betweenD15S211 (proximal recombination
in two affected individuals IV-3 and IV-4) andD15S979
(distal recombination in one affected individual, III-10)
(fig. 2). Linkage to 15q24 was excluded in four families
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Table 2
Pairwise Lod Scores between ADNFLE and Informative
Chromosome 15 Markers Mapping between D15S211 and
D15S979, for Families C, D, G, M, O, Q, and S
FAMILY AND
MARKER
LOD SCORE AT RECOMBINATION FRACTION OF
.00 .01 .05 .1 .2 .3 .4
C:
D15S211 .60 .59 .56 .51 .41 .29 .16
D15S1041 .30 .29 .26 .21 .13 .06 .02
D15S206 .60 .59 .56 .51 .41 .29 .16
D15S205 .30 .29 .26 .21 .13 .06 .02
D15S152 .60 .59 .56 .51 .41 .29 .16
D15S201 .60 .59 .56 .51 .41 .29 .16
D15S151 .60 .59 .56 .51 .41 .29 .16
D15S1030 .60 .59 .56 .51 .41 .29 .16
D15S979 .60 .59 .56 .51 .41 .29 .16
D:
D15S211 1.37 1.34 1.23 1.08 .77 .47 .21
D15S1041 1.28 1.26 1.15 1.01 .73 .45 .20
D15S206 .30 .28 .20 .11 .02 .07 .05
D15S205 .78 .76 .70 .62 .47 .32 .16
D15S152 .76 .74 .66 .57 .39 .23 .10
D15S201 .48 .47 .42 .37 .26 .17 .08
D15S151 .38 .37 .34 .30 .23 .16 .08
D15S1030 .95 .92 .82 .69 .44 .24 .10
D15S979 1.28 1.26 1.15 1.01 .73 .45 .20
G:
D15S211 2.79 .90 .29 .08 .03 .03 .01
D15S1041 .84 .82 .73 .63 .42 .22 .06
D15S200 2.81 .92 .31 .10 .02 .02 .01
D15S979 2.81 .92 .31 .10 .02 .02 .01
M:
D15S211 1.69 .96 .19 .55 .65 .45 .16
D15S1041 2.28 2.23 2.02 1.76 1.20 .65 .18
D15S206 2.16 2.12 1.95 1.72 1.27 .79 .34
D15S205 2.41 2.36 2.19 1.96 1.47 .94 .40
D15S152 3.01 2.96 2.74 2.46 1.85 1.19 .51
D15S201 2.01 1.97 1.82 1.63 1.22 .79 .37
D15S151 1.22 1.19 1.09 .96 .71 .47 .27
D15S1030 1.08 1.05 .94 .79 .53 .29 .12
D15S979 .95 .97 1.46 1.51 1.52 .83 .38
O:
D15S1041 3.80 1.40 .74 .48 .26 .16 .08
D15S205 .30 .29 .26 .21 .13 .06 .02
D15S152 3.80 1.70 1.00 .70 .40 .22 .10
D15S201 3.80 1.70 1.00 .70 .40 .22 .10
D15S979 3.80 1.40 .74 .48 .26 .16 .08
Q:
D15S1041 3.07 .88 .26 .06 .04 .04 .01
D15S205 6.35 3.65 1.94 1.15 .47 .18 .04
D15S152 2.80 2.24 1.06 .57 .19 .05 .01
D15S201 .32 .32 .31 .29 .23 .16 .08
D15S979 3.08 .89 .27 .08 .01 .01 .04
S:
D15S1041 3.40 2.53 1.26 .74 .30 .11 .02
D15S205 3.40 2.78 1.55 1.03 .55 .29 .11
D15S152 3.07 1.03 .39 .17 .01 .03 .02
D15S201 3.10 2.86 1.83 1.27 .72 .41 .19
D15S979 3.10 3.10 2.39 1.62 1.85 .45 .19
(families G, O, Q and S), by recombination (table 2). In
families C and D, there were no recombinants between
ADNFLE and markers from 15q24, but the families
were too small to be used to establish linkage (fig. 2 and
table 2).
Results of radiation-hybrid–panel mapping indicated
that D15S1227 was the marker closest to the three can-
didate genes CHRNA3, CHRNA5, and CHRNB4,
which places them betweenD15S114 andD15S1041 on
the Ge´ne´thon map (fig. 3). Since D15S211 (the marker
delineating the proximal limit for the ADNFLE region-
al localization) also maps between D15S114 and
D15S1041, these candidate genes must map to the 1.6-
cM interval between D15S211 and D15S1041, if any
of them are responsible for ADNFLE in family M.
SSCA of transmembrane-domain regions in exons 5
and 6 of CHRNA3 and CHRNA5 failed to detect any
band shift. However, sequencing revealed polymor-
phisms (not detected by SSCA) in exon 5 of CHRNA3
and in exon 5 of CHRNA5.
The CHRNA3 polymorphism is a conservative TrC
change at base 708 (GenBank accession number
M37981). Allele frequencies are as follows: .56 for the
C allele and .44 for the T allele, on the basis of data on
18 unrelated chromosomes. A mismatch primer was de-
signed to create an RsaI site in the allele carrying the C
at this position, so that the polymorphism could be de-
tected by PCR using primers A (5′-ATC ATC AAA GCC
CCA GGG TA-3′) and B (5′-AGT GAG GAA GGAGAT
GAG CA-3′), followed by digestion of the PCR product
by RsaI. This gave fragments of (a) 37 bp, 45 bp, and
71 bp for the T allele and (b) 18 bp, 19 bp, 45 bp, and
71 bp, for the C allele.
The CHRNA5 polymorphism is a conservative GrA
change at base 1340 (GenBank accession number
M83712), which destroys a TaqI site. PCR amplification
with primers A (5′-TCA TCG TTC TTC CTC AAC AC-
3′) and B (5′-CGG ACA TCA TTT TCC TTC AT-3′),
followed by digestion with TaqI, gives fragments of (a)
228 bp for the A allele and (b) 177 bp and 51 bp for
the G allele. Allele frequencies are as follows: .28 for
the A allele and .72 for the G allele, on the basis of data
on 54 unrelated chromosomes.
SSCA of exons 5 and 6 of CHRNB4 detected a band
shift in exon 5, with primers A (5′-ACG GGA CCT ATG
AGG TGT CT-3′) and B (5′-GGG AGT AAA GTC ATC
CAT GC-3′). Sequencing revealed that this was due to
a conservative CrT change at base 312 (GenBank ac-
cession number X68275), which destroys a CfoI site.
Digestion of the PCR product by CfoI gives fragments
of (a) 227 bp for the T allele and (b) 90 bp and 137 bp
for the C allele. Allele frequencies are as follows: .86 for
the C allele and .14 for the T allele, on the basis of data
on 66 unrelated chromosomes.
These polymorphisms could be useful for exclusion
Figure 2 Segregation of haplotypes in the three families consistent with linkage of ADNFLE to chromosome 15
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Figure 3 Ge´ne´thon linkage map of part of chromosome 15 in
proximity to CHRNA3, CHRNA5 and CHRNB4.
(by recombination) of the CHRNA3, CHRNA5, or
CHRNB4 genes as a cause of ADNFLE—or of any other
disorder for which they are candidates. They are appli-
cable to exclusion analysis of families too small to pro-
vide significant LOD scores by linkage analysis. None
of these polymorphisms are fully informative in families
M, C, and D, and, since no recombination with ADN-
FLE was observed, these genes remain candidates for
ADNFLE.
Discussion
ADNFLE is the prototype of a newly recognized group
of human partial epilepsies with monogenic inheritance
(Berkovic and Scheffer 1997). Localization of the gene
for ADNFLE in a large Australian family (Phillips et al.
1995) led to the identification of CHRNA4 as the first
gene to be implicated in a human idiopathic epilepsy
(Steinlein et al. 1995, 1997). Apart from two families
in whichCHRNA4mutations have been found, no other
mutations have been reported in other ADNFLE
families.
The distinctive clinical pattern of clusters of nocturnal
motor seizures is characteristic of epilepsy arising in the
frontal lobe. This phenotype can be observed in sporadic
cases with known frontal-lobe lesions such as tumors,
trauma, dysplasia, etc. Epileptologists also often observe
sporadic cases with no evidence, on magnetic-resonance
scans, of a structural lesion and with no history of brain
insult; it is unknown whether such cases have occult
lesions or are new mutations giving rise to ADNFLE.
Here we have shown that the two known CHRNA4
mutations are absent in seven other families with ADN-
FLE and in seven sporadic cases, suggesting that these
mutations are uncommon or rare causes of ADNFLE.
No other CHRNA4 mutations were found in the seven
sporadic cases. The use of intragenic CHRNA4markers
excluded linkage to CHRNA4 in the seven families (fig.
1), thus demonstrating genetic heterogeneity of this dis-
order, which is in agreement with recent findings of Ol-
dani et al. (1998).
The only possibly significant abnormality in our anal-
ysis of CHRNA4 was the rare variant in family S. It is
a nonconservative change (I257S) in the conserved trans-
membrane I domain. This domain is believed to form
part of the ion channel, and certain amino acid changes
in the transmembrane I domain of the muscle acetyl-
choline a–receptor subunit (N217K) and the transmem-
brane I domain of the muscle acetylcholine e subunit
(P245L) have been shown to cause slow-channel my-
asthenic syndrome, by slowing the rate of channel clos-
ing (Engel et al. 1996; Ohno et al. 1997). The relative
position of CHRNA4 codon 257 (according to the no-
menclature of GenBank accession number U62433) is
midway between these two. However, the mutation in
family S originates from the grandpaternal side of the
family whereas ADNFLE originates from the grand-
maternal side. Possible explanations could be that (1)
the amino acid involved may not face into the channel
opening and therefore has little or no effect on ion flow,
(2) this variant is part of the genetic background, acting
as a modifier to lower the seizure threshold, or (3) there
are two genes for ADNFLE that are segregating in this
family, one of which is CHRNA4 with a defective codon
257.
The exclusion of seven families from the CHRNA4
region, the localization of one family to chromosome
15, and, in other families, the exclusion of linkage to
chromosome 15 demonstrates the existence of at least
three genes responsible for ADNFLE. Some families with
this epilepsy syndrome do not show evidence of linkage
either to CHRNA4 (fig. 1; also see Oldani et al. 1998)
or near the CHRNA3/CHRNA5/CHRNB4 cluster on
chromosome 15 (table 2; also see Eng et al. 1991; Lopes-
Cendes et al. 1995). Families C and D, in which linkage
to 15q could not be excluded, and family M were not
included in the study by Lopes-Cendes et al. (1995),
which originally excluded ADNFLE from this region.
Mutation analysis of the transmembrane domains in
exons 5 and 6 of CHRNA3, CHRNA5, and CHRNB4
failed to detect any mutation. Although these genes re-
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main good candidates, the regional localization ofADN-
FLE on chromosome 15 is ∼6.3 cM, and the possibility
that a gene other than CHRNA3, CHRNA5, or
CHRNB4 is responsible for ADNFLE must not be over-
looked. The three subunits CHRNA3, CHRNA5, and
CHRNB4 are likely to be close to each other, given that
they are clustered within a 68-kb region in the rat ge-
nome (Boulter et al. 1990). Radiation-hybrid mapping
confirmed their close proximity in humans (fig. 3). Other
possible candidate genes in this region include the neu-
rotrophic tyrosine kinase receptor, type 3 (NTRK3),
which is preferentially expressed in brain and is thought
to be important in the development of certain areas of
the CNS, and neuromedin B (NMB), a bombesin-like
peptide widely distributed in mammalian neural and en-
docrine cells (OMIM; also see Pearson et al. 1994).
Families G, O, Q, and S have ADNFLE that is not
due to mutation in CHRNA4, and they show no sug-
gestion of linkage to 15q24. In family Q, linkage has
been excluded in this region (Lopes-Cendes et al. 1995),
which is one of the possible human chromosomal regions
homologous to the mouse region containing the El-1
mouse locus; the El mouse has spontaneous partial sei-
zures inherited in a complex manner (Rise et al. 1991).
Other neuronal nicotinic acetylcholine–receptor sub-
units are potential candidates as the cause of epilepsy in
these families. CHRNB2 on chromosome 1 is a prime
candidate, since it combines with CHRNA4 to form the
most common nicotinic acetylcholine receptor in the
brain (Schoepfer et al. 1988;Whiting et al. 1991; Sargent
1993). SSCA of exons 5 and 6 containing transmem-
brane domains did not detect any mutation ofCHRNB2
in affected individuals; however, SSCA does not detect
all mutations (Hayashi and Yandell 1993).
The findings presented here show that there are at least
three loci for ADNFLE. Pharmacological studies of the
two known CHRNA4 mutations have shown surpris-
ingly different effects in vitro, although both mutations
appear to impair calcium entry into neurons (Weiland
et al. 1996; Kuryatov et al. 1997; Steinlein et al. 1997).
Thus, it appears that a variety of basic molecular mech-
anisms can lead to the phenotype of ADNFLE, which
is clinically relatively homogeneous. This molecular het-
erogeneity will provide a challenge to the designing of
new rational therapies for ADNFLE. However, the hy-
pothesis that fundamentally the phenotype is due to im-
paired presynaptic nicotinic cholinergic transmission in
the frontal lobes remains attractive and is consistentwith
current molecular genetic and pharmacological data.
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